{
    "organizations": [],
    "uuid": "00055664346e2d3c9c7ad0acc7a5e9009df4bea1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-barry-honig-reports-499-pct-stake/brief-barry-honig-reports-4-99-pct-stake-in-mabvax-therapeutics-idUSFWN1Q30XW",
    "ord_in_thread": 0,
    "title": "Barry Honig Reports 4.99 Pct Stake In MabVax Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - MabVax Therapeutics Holdings Inc :\n* BARRY HONIG REPORTS 4.99 PERCENT STAKE IN MABVAX THERAPEUTICS HOLDINGS INC AS OF FEBRUARY 12, 2018 - SEC FILING‍​\n* BARRY HONIG SAYS MAY ENGAGE IN DISCUSSIONS WITH MANAGEMENT, SECURITY HOLDERS OF MABVAX REGARDING COMPLEXION OF CO’S BOARD OF DIRECTORS, OPTIONS FOR INCREASING SHAREHOLDER VALUE Source text: ( bit.ly/2EmknVf ) Further company coverage:\n ",
    "published": "2018-02-13T19:44:00.000+02:00",
    "crawled": "2018-02-14T12:27:16.073+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "mabvax",
        "therapeutic",
        "holding",
        "inc",
        "barry",
        "honig",
        "report",
        "percent",
        "stake",
        "mabvax",
        "therapeutic",
        "holding",
        "inc",
        "february",
        "sec",
        "barry",
        "honig",
        "say",
        "may",
        "engage",
        "discussion",
        "management",
        "security",
        "holder",
        "mabvax",
        "regarding",
        "complexion",
        "co",
        "board",
        "director",
        "option",
        "increasing",
        "shareholder",
        "value",
        "source",
        "text",
        "company",
        "coverage"
    ]
}